Multimineral 5 weeks

Adult administration

Use according to a physician's prescription, checking plasma trace element levels to guide dosage adjustments. For metabolically stable parenteral nutrition patients: zinc 2.5-4mg per day, copper 0.5-1.5mg, manganese 0.15-0.8mg, chromium 10-15μg, selenium 20-40μg. For metabolically stable patients with small intestine fluid loss: an additional 12.2mg/L (amount of small intestine fluid loss) or 17.1mg/kg (output volume). Acute

Child administration

Pediatric patients - under 5 years: zinc 100μg per kg of body weight per day, copper 20μg, manganese 2-10μg, chromium 0.14-0.20μg, selenium 3μg

This product contains benzyl alcohol, which can cause life-threatening respiratory problems in premature infants, and should not be used in newborns or premature infants. Administering this medication directly into the vein without dilution may cause phlebitis, so it must always be diluted before use. Since this is a hypo-osmotic solution, it can only be used for mixed injections and should not be administered alone. If any toxic symptoms appear from any component of the medication, administration must be immediately stopped. Parenteral nutrition solutions contain aluminum, which may cause toxicity when administered for a long period to patients with impaired kidney function or premature infants, so caution is necessary. Before administration, the physician must accurately assess the patient's condition and metabolic requirements, and frequently check serum trace element concentrations to adjust the dosage. Patients with renal failure may have difficulties excreting zinc, causing accumulation in the body, so caution is required. Patients with biliary obstruction may have difficulties excreting copper and manganese, resulting in accumulation in the body, and should be monitored closely. Chromium is primarily excreted through the kidneys, and for diabetic patients, interactions with diabetic medications must be taken into account. Selenium requires dose adjustments in patients with impaired kidney and gastrointestinal functions, and the effects of transfusions should also be considered in patients who have received blood transfusions. The safety of this medication during pregnancy has not been established, thus should only be administered to pregnant women or those potentially pregnant when the therapeutic benefits outweigh the risks. Excessive doses may lead to toxicity symptoms of zinc, copper, chromium, selenium, etc., so the dosage must be strictly adhered to, and if toxicity symptoms are suspected, consult medical staff immediately. This product must be used according to a physician's prescription, and when added to parenteral nutrition solutions, sterile conditions must be maintained. Prior to administration, ensure the solution is not discolored or contains particles, and store it in a dry, cool place away from children.

Serious side effects

• Hypotension
• pulmonary edema
• jaundice
• decreased urine output
• coma

Mild side effects

• Sweating
• decreased consciousness
• blurred vision
• tachycardia
• hypothermia
• diarrhea
• vomiting
• exhaustion
• changes in behavior
• progressive wasting

This medication should be stored in a sealed container to protect it from air and moisture, and it is important to maintain the storage temperature between 15 degrees and 30 degrees. This ensures the medication's efficacy remains intact.

Appearance

A colorless, odorless, or pale blue transparent solution in a colorless transparent vial injection

Package unit

10mL*10vial